Navigation Links
Reportlinker Adds Biomarkers - Technologies, Markets and Companies
Date:6/3/2010

Vaccines 83

Live attenuated influenza vaccine vs. inactivated vaccine 84

Vaccines for H1N1 influenza 84

Vaccines in development 85

Cell culture-derived influenza vaccines 85

DNA vaccines for avian influenza 86

Epitope-based vaccines for influenza 86

Gene-based vaccines for influenza 87

MAbs for passive immunization against avian influenza 87

M2e-based human influenza A vaccine. 87

MF-59 as adjuvant for influenza vaccine 88

Pre-pandemic split antigen H5N1 vaccine 88

Recombinant hemagglutinin influenza vaccine 89

Synthetic avian influenza vaccine 89

Virus-like particles as influenza vaccines 90

Current status of influenza vaccines and limitations 91

Current recommendations for influenza vaccination 91

Limitations of current influenza vaccines 91

Needs of influenza vaccines 92

Problems with demand and supply of influenza vaccines 93

Problems with access to virus samples 93

FluVac project for development of pandemic influenza vaccine 94

Influenza vaccines for multiple strains of the disease 94

Current status of vaccine preparedness against seasonal influenza 94

Current status of vaccine preparedness against H5N1 95

RNAi-based approaches 95


'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. Reportlinker Adds Future of Red Biotechnology in China
2. Reportlinker Adds The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
3. Reportlinker Adds the Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
4. Reportlinker Adds SNP Genotyping and Analysis Markets
5. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
6. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
7. Reportlinker Adds Biotechnology Instrumentation - International Market Trends
8. Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective
9. Reportlinker Adds Pharmacodynamic Assays
10. Reportlinker Adds Neurostimulation - A Global Market Perspective
11. Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... release is available in German . ... well: with the naked eye, you can see which branch ... the blur of branches through the telephoto lens for high-magnification ... researchers who are looking to study proteins, the active biomolecules ... Zurich,s Institute for Molecular Systems Biology, and her colleagues have ...
(Date:5/17/2013)... , May 17, 2013  Cellular Biomedicine ... achieved 50% enrollment of the total projected enrollment ... the safety and preliminary efficacy of the medical ... for Knee Osteoarthritis (KOA). To date the trial ... The Phase I open label clinical ...
(Date:5/17/2013)... Toronto, Canada (PRWEB) May 17, 2013 ... to understanding complex biological systems that can help predict ... Keynote speaker Dr. Sergey Stepaniants, Head of Computational Biology ... of computational biology tools to ensure high-quality genomics when ... tools can be applied to complex data sets to ...
(Date:5/16/2013)... The Stirling Ultracold Model SU780U ... OH, USA, won the Outstanding New Product Award presented ... Biological and Environmental Repositories (ISBER) at their annual meeting ... annually, recognizes the company’s development and introduction of the ... award was presented to Global Cooling’s CEO Neill Lane ...
Breaking Biology Technology:Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), today ... accepted for poster presentations and an oral presentation at ... Society. This meeting will be held October 1-5, 2011 ... Details on the presentation times are ...
... the UC Davis School of Medicine have outlined several ... is currently under scrutiny by the U.S. National Institutes ... Science Translational Medicine in a focus article titled, ... online at www.ScienceTranslationalMedicine.org . "In this ...
... Sciences International, Inc. (Nasdaq: BDSI ) announced ... 3 clinical study of BEMA Buprenorphine for the treatment ... opioid naive and opioid experienced population.  The primary endpoint ... Buprenorphine and placebo, was not achieved; however, BDSI believes ...
Cached Biology Technology:Orexigen® Therapeutics Announces Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society 2UC Davis advocates for new approaches to biomedical research 2UC Davis advocates for new approaches to biomedical research 3BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain 2BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain 3BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain 4BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain 5BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain 6
(Date:5/15/2013)... occurring "keystone" molecules that have powerful behavioral effects ... roles in structuring ecosystems, according to a theory ... . The authors of the theory, Ryan P. ... Zimmer of the University of California at Los ... or plants that may be uncommon but exert ...
(Date:5/15/2013)... Canada,s goal of reducing greenhouse gas (GHG) emissions to ... year 2020, federal and provincial governments, led by the ... what portion of the total GHG reduction will be ... of Toronto,s School of the Environment. Their report ... governments, opposition parties and other participants in the climate ...
(Date:5/15/2013)... of its strategic plan, " Forging the Future ... Energy Joint Genome Institute (DOE JGI) has positioned itself ... their users so that they can address pressing energy ... early step in this process is the launch of ... primary purpose of the ETOP is to develop and ...
Breaking Biology News(10 mins):Natural 'keystone molecules' punch over their weight in ecosystems 2Canada must addess real climate-change challenge 2Canada must addess real climate-change challenge 3The DOE Joint Genome Institute expands capabilities via new partnerships 2The DOE Joint Genome Institute expands capabilities via new partnerships 3
... French . , Montreal, April 8, 2009 ... its affiliated research centres has received a boost, thanks to ... the Government of Quebec and the private sector. The CFI ... the Universit de Montral, the Sainte-Justine University Hospital Research Center ...
... University are looking to soy as a way to make ... dog and less costly for the owners. Dr. Steven ... genistein - a molecule found in soy that has been ... cells in humans - to determine whether it would also ...
... new therapy for metastatic prostate cancer has shown considerable promise ... resistant to current drugs. , Of 30 men who ... phase I/II trial designed to evaluate safety, 22 showed a ... in their blood. Phase III clinical trials are planned to ...
Cached Biology News:CFI awards $854,098 to University of Montreal and partners 2CFI awards $854,098 to University of Montreal and partners 3New medications show promise in treating drug-resistant prostate cancer 2New medications show promise in treating drug-resistant prostate cancer 3New medications show promise in treating drug-resistant prostate cancer 4
Applications: Immunohistochemistry, ISH, FISH, CISH....
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
Request Info...
...
Biology Products: